Cause of death, by non-communicable diseases, ages 60+, female in Algeria
Algeria: Cause of death, by non-communicable diseases, ages 60+, female was 89.1% in 2021. ▼ Falling
Cause of death, by non-communicable diseases, ages 60+, female in Algeria, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total female deaths ages 60+.
Analysis
In 2021, cause of death, by non-communicable diseases, ages 60+, female in Algeria stood at 89.1%.
Compared with earlier readings it is up 11.6% on the previous year and down 4.5% over ten years.
Over the whole period, cause of death, by non-communicable diseases, ages 60+, female in Algeria peaked at 94.2% in 2019 and was at its lowest, 79.8%, in 2020.
Algeria ranks 12th of 185 countries on this measure, in the top 10%.
Cause of death, by non-communicable diseases, ages 60+, female in Algeria, year by year
| Year | % of total female deaths ages 60+ | Change |
|---|---|---|
| 2000 | 93.3% | — |
| 2010 | 93.3% | -0.0% |
| 2015 | 93.6% | +0.3% |
| 2019 | 94.2% | +0.6% |
| 2020 | 79.8% | -15.2% |
| 2021 | 89.1% | +11.6% |
Algeria compared with similar countries
- Algeria's 89.1% is above the median for upper middle income countries, which is 73.7%, 1.2× the median. (55 countries reporting)
- Algeria's 89.1% is above the median for Middle East, North Africa, Afghanistan & Pakistan, which is 77.1%, 1.2× the median. (23 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 93.3% | 93.3% | 93.3% | 1 |
| 2010s | 93.7% | 93.3% | 94.2% | 3 |
| 2020s | 84.4% | 79.8% | 89.1% | 2 |
Countries ranked near Algeria
More health data for Algeria
- Un projection of annual infant deaths, annual growth rate -1.82 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.5437 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 943.1 deaths per 1,000 people (2090)
- Number of infants who die before age 1 1,455 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -2.77 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0465 units per person (2025)
- Population ages 00-04, male, annual growth rate -2.77 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, ages 60+, female in Algeria?
- Cause of death, by non-communicable diseases, ages 60+, female in Algeria was 89.1% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, ages 60+, female recorded in Algeria?
- The highest recorded value was 94.2% in 2019.
- What is the lowest cause of death, by non-communicable diseases, ages 60+, female recorded in Algeria?
- The lowest recorded value was 79.8% in 2020.
- How does Algeria rank for cause of death, by non-communicable diseases, ages 60+, female?
- Algeria ranks 12th out of 185 countries with data for 2021.
- Is cause of death, by non-communicable diseases, ages 60+, female rising or falling in Algeria?
- Over the last ten years it is down 4.5%. The long-run trend across the full record is falling.
- Where does this Algeria data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, ages 60+, female (% of total female deaths ages 60+). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of female deaths ages 60+ due to non-communicable diseases divided by number of all female deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.